Directors

小野 高

Takashi Ono, Ph.D.

President and Chief Executive Officer

  • Joined as Chief Operating Officer in 2018 and assumed as CEO in March 2019
  • Project Manager, ITOCHU Corporation in 2009
  • (concurrently VP Business Development, Solasia Pharma K. K.)
  • General Manager of Business Development, Nxera Pharma Co., Ltd. (formarly Sosei Co., Ltd.) in 2002

大年 寿子

Hisako Otoshi

Chief Financial Officer

  • Joined as CFO in October 2020
  • VP Administration, Solasia Pharma K. K.in 2014
  • Board member, au Payment Corporation (formerly Webmoney Corporation) in 2009
  • Executive Officer, Faith, Inc. in 2005

八木 祐介

Yusuke Yagi, Ph.D.

Chief Technical Officer

  • Founder of EditForce, Inc. and assumed as CTO in March 2019
  • Director of Research & Development from 2016
  • Specialist of PPR protein, establishing the basis of PPR Platform Technology at Kyushu University from 2011

中西 理

Osamu Nakanishi, Ph.D.

Chief Scientific Officer

  • Joined as Director of Research & Development in March 2020 and assumed as CSO in August 2020
  • Head of West Japan Office, Department of drug discovery, Japan Agency for Medical Research and Development(AMED) in 2015
  • Head of West Japan Office, Center for drug discovery, National Institutes of Biomedical Innovation, Health and Nutrition (formarly National Institute of Biomedical Innovation) in 2013 after working for several pharmaceutical companies

Non-executive directors

Atsushi Usami

Partner and Board Director, The University of Tokyo Edge Capital Partners Co., Ltd.

Koji Abe

General Partner, ITOCHU Technology Ventures, Inc.

Toshiyuki Mori

Representative Partner, TM Partners LLC

Ryutaro Adachi

Senior Manager, Regional Economy Vitalization Corporation of Japan
Certified Public Accountant

Michihiko Wada

Advisor, Clinical and Medical Sciences, Newton Biocapital Partners

Manabu Morimoto

President, Japan Securities Research Institute

Audit & Supervisory Board Member

Tomotaka Goji

Managing Partner, CEO and President, The University of Tokyo Edge Capital Partners Co., Ltd.

Nobuyasu Ogata

Chief Lawyer, Ogata Law Firm

Scientific Advisory Board

Takahiro Nakamura（Chairman）

Prof., School of Agriculture, Graduate School of Kyushu Univ.

Takashi Yamamoto

Prof., Graduate school of Integrated Sciences for Life, Hiroshima Univ.

Osamu Sugita

Former Vice Director,Hokkaido University Hospital, Clinical Research and Medical Innovation Center.

Guy Heynen

Chief Clinical and Regulatory Officer of Bone Therapeutics Independent Director of Ogeda and Pluriomics